Product logins

Find logins to all Clarivate products below.


Orthopedic Surgical Robotic Devices | Market Insights | Global | 2022

In 2020, the global orthopedic surgical robotic device market was significantly impacted by the COVID-19 pandemic but will nevertheless still grow strongly through 2030. This will be driven by rising robotic-assisted procedure volumes, growing demand for minimally invasive surgery, increasing acceptance and adoption of surgical robotic technology, the launch of new and innovative robotic systems, and an increase in clinical evidence that supports the benefits of robotic surgery.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for orthopedic surgical robotic devices in the US, Europe, and the Asia Pacific region across an 11-year period.

Related Medtech Insights Reports

Report
Spinal Implants – Market Insights – United States
The US spinal implant market will experience steady growth, supported by demographic trends, increased adoption of minimally invasive procedures, robotics and navigation technologies, premium…
Report
Orthopedic Surgical Robotic Devices – Market Insights – Global
The growing adoption of robot-assisted procedures across large-joint replacement and spinal fusion applications, combined with ongoing technological advancements such as real-time 3-D planning,…
Report
Large-Joint Reconstructive Implants – Market Insights – Europe
The European large-joint reconstructive implant market is poised for long-term sustained growth, driven by the adoption of innovative technologies such as 3-D printed implants and smart implants,…
Report
Small-Joint Reconstructive Implants – Market Insights – Japan
The Japanese smalljoint reconstructive implant market, covering shoulder and elbow arthroplasty, exhibits longterm growth potential. Procedure volumes are rising steadily, driven by Japan’s…
Report
Minimally Invasive Vertebral Compression Fracture Treatments – Market Insights – Global
The MIVCF treatment market is expected to show modest growth through 2035, largely driven by positive clinical results, adoption of AI for MIVCF detection, favorable demographics, and increasing…